References
- Garrod PL, Lambert HP, O’Grady F. Antibiotics and Chemotherapy. UK: Churchill Livingstone, 1981 58–93.
- Sykes RB. The classification and terminology of enzymes that hydrolyze beta-lactam antibiotics. J Infect Dis 1982; 145: 762–765.
- Madeiros AA. Beta-lactamases. Br Med Bull 1982; 40: 18–27.
- O’Brien TF. Resistance of bacteria to antibacterial agents: report of task force 2. Rev Infect Dis 1987; 9, Suppl. 3: 244–260.
- Schito GC, Varaldo PE. Trends in the epidemiology and antibiotic resistance of clinical Staphylococcus strains in Italy-A review. J Antimicrob Chemother 1988; 21 Suppl. C: 67–78.
- Bush K, Sykes RB. Beta-lactamase inhibitors in perspective. J Antimicrob Chemother 1983; 11: 97–107.
- Retsema JA, Schelkly WU, Girard AE, English AR. Beta-lactamase inhibitor CP-45–899 (sulbactam) mode of action against a type III beta-lactamase and synergy effects with cephalosporins. Drugs Under Exper Clin Res 1981; 7: 255–61.
- Knowles JR. Anti-beta-lactamase agents. In: Hand FE, ed. Antibiotic, VI Modes and mechanisms of microbial growth inhibitors. Berlin: Springer Verlag 1983: 90–107.
- Retsema JA, English AR, Girard AE. CP-45,899 in combination with penicillin or ampicillin against penicillinresistant Staphylococcus, Haemophilus influenzae, and Bacteroides. Antimicrob Agents Chemother 1980; 17: 615–22.
- English AR, Retsema JA, Girard AE, Lynch JE, Bart WE. CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization. Antimicrob Agents Chemother 1978; 14: 414–9.
- Debbia E, Varaldo PE, Schito GC. In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin. Antimicrob Agents Chemother 1986; 30: 813–815.
- Debbia E, Pesce A, Schito GC. In vitro activity of LY146032 alone and in combination with other antibiotics against Gram-positive bacteria. Antimicrob Agents Che mother, 1988; 32: 279–281.
- Retsema JA, English AR, Girard A, et al. Sulbactam/Ampicillin: In vitro spectrum, potency, and activity in models of acute infection. Rev Infect Dis 1986; 8, Suppl.5 528–534.
- Nichols RL. Infections following gastrointestinal surgery. Surg Clin North Am 1980; 60: 197–212.
- Gemmel GG. The staphylococcus – new features 100 years after its discovery. J Infect 1982; 1:5–15.